The roll-out of Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s breakthrough erectile dysfunction (ED) gel continues apace with sales starting in the company's first market in the Middle East.
Eroxon will now be for sale online through the BinSina Pharmacy in the United Arab Emirates, adding to the sales momentum coming from the UK and Belgium.
In a recent Proactive interview, Futura CEO James Barder said of the commercial impetus: "The early signs are very encouraging; we've achieved around a 20% market share in the segment of clinically proven erectile dysfunction treatments."
Eroxon has been developed as a fast-onset alternative for men who struggle with the side-effects of traditional blue pill treatments. The product is the only erectile dysfunction treatment approved by the US Food & Drug Administration to be sold over the counter.